Expect Equity LLC Acquires New Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Expect Equity LLC acquired a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The fund acquired 76,261 shares of the company's stock, valued at approximately $1,769,000.

Other large investors have also recently made changes to their positions in the company. Murphy & Mullick Capital Management Corp purchased a new position in Option Care Health in the 4th quarter worth approximately $26,000. UMB Bank n.a. lifted its holdings in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after purchasing an additional 346 shares in the last quarter. Signaturefd LLC lifted its holdings in Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC lifted its holdings in Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after purchasing an additional 1,099 shares in the last quarter. Finally, Johnson Financial Group Inc. purchased a new position in Option Care Health in the 4th quarter worth approximately $47,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.64% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on OPCH. Barrington Research reissued an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 30th. JPMorgan Chase & Co. upped their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and upped their price objective for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a report on Tuesday, April 22nd. Finally, UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Stock Up 1.2%

Shares of Option Care Health stock traded up $0.38 during trading on Wednesday, hitting $31.94. 643,277 shares of the stock traded hands, compared to its average volume of 1,850,059. The firm has a market cap of $5.23 billion, a P/E ratio of 26.84, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The stock's fifty day simple moving average is $33.13 and its 200 day simple moving average is $28.92.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same quarter last year, the firm posted $0.26 earnings per share. The business's revenue for the quarter was up 16.3% on a year-over-year basis. On average, equities analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.